TABLE 1: Executive summary

Executive summary
Target not reached or not in line with other registries
Target attained
Indicator Country average (population) Country average (country) England Scotland Wales Northern Ireland
Stability: Percentage change (%) for all cancers (C00-C97 ex. C44) in 2017 compared with 2014-20161 0.2% 0.0% 0.3% -0.8% -0.3% 0.6%
Registry Creep: Percentage (%) for all cancers (C00-C97 ex. C44) of 2016 registrations between 02/02/2019 to 01/03/2019 compared with registrations at 31/01/20187. 1.6% 2.4% 1.4% 4.0% 1.6% 2.6%
Staging: Proportion (%) of all cases (C00-C97 ex. C44) with valid known stage registered out of all 2017 registered cancers (C00-C97 ex. C44)2 80.6% 78.6% 81.9% 67.5% 79.7% 85.3%
Average of Core Patient Information Complete: Average percentage (%) of all cancers (C00-C97 ex. C44) registered with demographic information3 98.6% 96.9% 99.3% 96.5% 91.9% 100.0%
Average of Core Tumour Information Complete: Average percentage (%) of all cancers (C00-C97 ex. C44) registered with tumour information4 97.3% 96.9% 97.4% 96.1% 97.1% 97.2%
Diagnosing Hospital Known: Percentage (%) of all cancers (C00-C97 ex. C44) registered with an organisation of diagnosis 97.7% 96.9% 98.2% 93.0% 98.2% 98.1%
Death Certificate Only (DCO) Rates: Percentage (%) of all cancers (C00-C97 ex. C44) registered as a DCO5 0.6% 0.6% 0.6% 0.2% 1.3% 0.3%
Zero Day Survivors: Percentage (%) of all cancers (C00-C97 ex. C44) registered with the date of death equals the date of diagnosis5 1.2% 1.0% 1.3% 0.5% 1.6% 0.6%
Microscopically Verified: Percentage (%) of all cancers (C00-C97 ex. C44) that are microscopically verified 84.8% 84.3% 85.1% 82.1% 83.4% 86.3%
Non Specific Codes: Percentage (%) of all cancers (C00-C97 ex. C44) that are microscopically verified with non specific morphology codes 1.2% 1.3% 1.2% 1.1% 1.5% 1.6%
Grade: Percentage (%) of all cancers (C00-C97 ex. C44) registered with a known grade 59.6% 61.3% 59.4% 59.0% 61.1% 65.6%
Treatment: Percentage (%) of all cancers (C00-C97 ex. C44) registered with any treatment 86.6% 78.4% 89.2% 68.0% 84.8% 71.9%
Breast Screening Data: Percentage of breast cancer (C50) cases from 2016 screen detected for ages 50-646 42.2% 48.2% 40.8% 48.0% 55.8% NA
Cervical Screening Data: Percentage of cervical cancer (C53) cases from 2016 screen detected for ages 25-606 28.6% 38.0% 25.6% 50.4% NA NA
Bowel Screening Data: Percentage of bowel cancer (C18-C20) cases from 2016 screen detected for ages 60-696 4.4% 19.2% 0.0% 29.2% 28.4% NA
  1. Data for Wales is for 2016 throughout unless otherwise specified (here 2016 compared with 2013-2015)
  2. Staging target: > 70%
  3. Core Patient information includes name, address, postcode, sex, date of birth, ethnicity, date of death, unique health identifier
  4. Core Tumour information includes date of diagnosis, site of primary growth, type of growth, behaviour of growth, basis of diagnosis, hospital of diagnosis
  5. DCO and zero survivor rate targets: <2%
  6. Screening data for Wales is for 2015
  7. England & Wales 02/02/2019, Scotland 01/03/2019 & Northern Ireland 28/02/2019
NA – not available (average excludes corresponding country)

1 Data for Wales is on the preceding year.